Congress / BROOKINGS INSTITUTION / Senate Finance / National Institute of Health / Senate Finance Committee / Food and Drug Administration / House of Representatives / Commission on Science and Technology / FDA / Commerce Committee / Committee of Energy and Commerce / Health Subcommittee / American Enterprise Institute / Energy and Commerce Committee / Senate / Medicare / /
Person
GREGG H. ALTON / SCOTT GOTTLIEB / Wyden / MICHAEL C. BURGESS / Henry Waxman / MARK B. MCCLELLAN / DAN MENDELSON / DIRK CALCOEN / /
PoliticalEvent
presidential election / /
Position
Governor / chairman / president / congressman / administrator / chair / REPRESENTATIVE / Senator / leader / their majority leader / /
Product
iPhone / /
ProvinceOrState
Texas District / Denton County / /
Technology
gene therapy / cellular telephone / information technology / drug development / /
AMERICAN ENTERPRISE INSTITUTE HOW WILL WE PAY FOR THE COST OF CURES? OPENING DISCUSSION: IMPROVING THE CRITICAL PATH FOR DEVELOPING CURES REPRESENTATIVE MICHAEL C. BURGESS, (R-TX)